Real-World US Treatment Patterns and Clinical Outcomes in Advanced NSCLC After Prior Platinum Chemotherapy and Immunotherapy

被引：0
|
作者：
Smith, T. [1 ]
Knoll, S. [1 ]
Martinalbo, J. [2 ]
Ye, F. [1 ]
Kolaei, F. [2 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Novartis Oncol, Basel, Switzerland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
Advanced NSCLC; post-ICI and PDC; real-world evidence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10.07
引用
收藏
页码：S1001 / S1001
页数：1
相关论文
共 50 条
  • [1] Real-World Treatment Patterns and Outcomes in Patients With Advanced NSCLC Treated After Prior Chemotherapy and Immunotherapy
    Haggstrom, D.
    Mhatre, S. K.
    Chen, F.
    Gao, R.
    Carroll, C.
    Patel, R.
    Park, J.
    Descoteaux, A.
    Stokes, M.
    Daniel, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S409 - S409
  • [2] Treatment Patterns and Outcomes in Second-Line Advanced NSCLC Treated After Prior Platinum Chemotherapy and Immunotherapy Combination Therapy: A Real -World Study
    Daniel, Davey
    Gao, Ran
    Mhatre, Shivani K.
    Carroll, Charlotte
    Patel, Riddhi
    Park, Joseph
    Haggstrom, Daniel
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E49 - E49
  • [3] Clinical Outcomes of Real-World Treatment for Metastatic EGFRm NSCLC after Osimertinib and Platinum-Based Chemotherapy
    Patel, J.
    Meng, J.
    Le, H.
    Tanaka, Y.
    Phani, S.
    Wu, C.
    Salas, M.
    Sternberg, D.
    Esker, S.
    Sun, H.
    Lieb, C.
    Reckammp, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S411 - S411
  • [4] US real-world immunotherapy-based treatment patterns and clinical outcomes of advanced NSCLC (aNSCLC) patients in the first-line setting
    Bittoni, M. A.
    Divan, H. A.
    Krishna, A.
    Gosset, S.
    Carbone, D. P.
    ANNALS OF ONCOLOGY, 2021, 32 : S1416 - S1416
  • [5] Real-World Treatment Patterns and Clinical Outcomes in Advanced/Metastatic NSCLC Patients in England
    Verleger, Katharina
    Hertel, Nadine
    Solem, Caitlyn
    Penrod, John R.
    Macahilig, Cynthia
    Luo, Linlin
    Crawford, S. Michael
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 5 - 5
  • [6] REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC NSCLC AFTER RECEIVING FIRST-LINE PEMBROLIZUMAB WITH PEMETREXED/PLATINUM CHEMOTHERAPY IN THE US ONCOLOGY NETWORK
    Goldschmidt, Jerome
    Annavarapu, Srinivas
    Venkatasetty, Divea
    Santorelli, Melissa
    Burke, Thomas
    Pennell, Nathan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A974 - A975
  • [7] Real-World treatment outcomes for advanced NSCLC in Greece
    Kokkotou, Eleni
    Stournara, Lamprini
    Mani, Maria
    Gkiozos, Ioannis
    Tsagouli, Sofia
    Syrigos, Nikolaos
    Burke, Thomas
    Desiniotis, Andreas
    Dimitriadis, Ioannis
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan
    Nokihara, Hiroshi
    Kijima, Takashi
    Yokoyama, Toshihide
    Kagamu, Hiroshi
    Suzuki, Takuji
    Mori, Masahide
    Santorelli, Melissa L.
    Taniguchi, Kazuko
    Kamitani, Tetsu
    Irisawa, Masato
    Kanda, Kingo
    Abe, Machiko
    Burke, Thomas
    Goto, Yasushi
    CANCERS, 2022, 14 (12)
  • [9] Real-world treatments and clinical outcomes in advanced NSCLC without actionable mutations after introduction of immunotherapy (IO) in Japan
    Nokihara, H.
    Santorelli, M. L.
    Taniguchi, K.
    Kamitani, T.
    Irisawa, M.
    Kanda, K.
    Abe, M.
    Burke, T.
    Goto, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S1014 - S1014
  • [10] Treatment patterns, outcomes and clinical characteristics in advanced renal cell carcinoma: a real-world US study
    Hall, Jennifer P.
    Zanotti, Giovanni
    Kim, Ruth
    Krulewicz, Stan P.
    Leith, Andrea
    Bailey, Abigail
    Liu, Frank X.
    Kearney, Mairead
    FUTURE ONCOLOGY, 2020, 16 (36) : 3045 - 3060
12345